This is the AHEAD clinical trial, an international multicenter study to evaluate the efficacy and safety of lecanemab
AD / PD 2022, held this year in Barcelona, presents work carried out at the Pasqual Maragall Foundation’s research center, in three oral presentations and a poster. In addition, one of our researchers will moderate a symposium of the congress
The study's innovative design has allowed researchers to detect that carriers of the apoe-ε4 gene, linked to an increased risk of developing Alzheimer's, have an accumulation of early amyloid protein in the hippocampal area
This has been demonstrated in a study by BBRC researchers, published in Alzheimer's & Dementia, in which they have studied the protective effect against malaise and its link to major volumes of gray matter
The study, which began in May 2018, looked at the risk of developing dementia five years ahead, in people with subjective memory complaints
Juan de la Cierva-Incorporación grants, awarded by the State Research Agency, fund postdoctoral research training in Spanish research centers for three years.
Gemma Salvadó joined the BBRC Neuroimaging Group in 2017 as a pre-doctoral researcher, where she collaborated until 2021. She is currently continuing her research on Alzheimer’s at Lund University (Sweden).
Once again, we support women’s awareness-raising activities in science.
The Clinical Research Group on Risk Factors for Neurodegenerative Diseases will promote research, from an integrative and clinical perspective, in the prevention of Alzheimer's disease and research on healthy aging.